SEARCH RESULTS
Members
Show All
470 Members
Teams
Show All
114 Teams
Challenges
Show All
22 Challenges
News
.png)
Report Cards
This project is investigating whether targeting a particular protein called TRIM24 could serve as a potential therapy for men with castrate resistant prostate cancer. The funded work will be conducted using pre-clinical models has implications for drug development, and if successful could lead to the initiation of clinical trials for men with advanced prostate cancer.
To research and define the in vitro benefit of heart glycosides and similar substances combined with standard prostate cancer pharmaceuticals such as cytotoxic drugs in the advanced stages of prostate cancer.
General
Prostate Cancer
Strategy
Snapshot
The results we seek
Men living with and beyond prostate cancer have the treatment and care needed to be physically and mentally well.
How do we measure progress?
Prostate cancer mortality rate
We want men with prostate cancer to say:
My information, care, treatment and support needs have been met
I had access to well-coordinated advice, treatment and care
I made a well-informed treatment decision that I do not regret
I had access to the treatment of my choice
The practical support needs of my partner, family, caregivers and I have been
As a charity operating in 21 countries, the Movember Foundation is required to comply with a range of regulatory and governance obligations. These obligations are taken very seriously and the Foundation is committed to best practice levels of transparency, accountability and governance.
THE MOVEMBER FOUNDATION BOARD
The Movember Foundation is governed by a Board, which is accountable to the Movember community and general public. Its role is to ensure the Foundation maintains the highest standards of performance, governance, accountability, transparency and cost to fundraising ratios. In
